{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:54:42Z","timestamp":1783036482800,"version":"3.54.6"},"reference-count":14,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1731,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2710.2010.01234.x","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T02:05:26Z","timestamp":1291601126000},"page":"117-121","source":"Crossref","is-referenced-by-count":22,"title":["Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease"],"prefix":"10.1155","volume":"37","author":[{"given":"Y.","family":"Horai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2010,12,5]]},"reference":[{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1756-185X.2009.01457.x","article-title":"Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis","volume":"13","author":"Katikireddi","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.3800333","article-title":"Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy","volume":"18","author":"Yousem","year":"2005","journal-title":"Modern Pathology"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB8|cit8","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"The Journal of Rheumatology"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2007.04.028","article-title":"Exacerbation of interstitial lung disease during etanercept therapy: two cases","volume":"75","author":"Tournadre","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10165-006-0457-7","article-title":"Guidelines for the proper use of etanercept in Japan","volume":"16","author":"Miyasaka","year":"2006","journal-title":"Modern Rheumatology"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.080791","article-title":"Postmarketing surveillance of the safety and effectiveness of etanercept in Japan","volume":"36","author":"Koike","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1164\/ajrccm.152.6.8520791","article-title":"Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha","volume":"152","author":"Kapanci","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","article-title":"Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial","volume":"178","author":"Raghu","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1111\/j.1365-2710.2010.01234.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.170.1.567","article-title":"Repression of bleomycin-induced pneumopathy by TNF","volume":"170","author":"Kuroki","year":"2003","journal-title":"Journal of Immunology"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2010.01234.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2010.01234.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:03Z","timestamp":1671818643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2010.01234.x"}},"subtitle":["Eternacept and concurrent interstitial lung disease"],"short-title":[],"issued":{"date-parts":[[2010,12,5]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2010.01234.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,5]]}}}